Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Improving oncologic outcomes for women with endometrial cancer: realigning our sights.

Dowdy SC.

Gynecol Oncol. 2014 May;133(2):370-4. doi: 10.1016/j.ygyno.2014.02.019. Epub 2014 Feb 20. Review.

2.

Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.

Yang YH, Chen RJ, Lin MC, Cheng SP, Chang TC.

Taiwan J Obstet Gynecol. 2010 Mar;49(1):97-100. doi: 10.1016/S1028-4559(10)60019-8. No abstract available.

3.

The diagnosis and treatment of endometrial cancer: progress and controversies.

Denschlag D, Ulrich U, Emons G.

Dtsch Arztebl Int. 2010 Aug;108(34-35):571-7. doi: 10.3238/arztebl.2011.0571. Epub 2010 Aug 29. Review.

4.

A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy.

Rauh-Hain JA, Costaaggini I, Olawaiye AB, Growdon WB, Horowitz NS, del Carmen MG.

Eur J Gynaecol Oncol. 2010;31(3):284-7.

PMID:
21077469
5.

[Impact of surgical resection extent on the prognosis of clinical stage I endometrial carcinoma].

Yan X, Gao YN, Jiang GQ, Gao M, An N.

Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):208-12. Chinese.

PMID:
19615262
6.

Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.

Narayan K, Khaw P, Bernshaw D, Mileshkin L, Kondalsamy-Chennakesavan S.

Int J Gynecol Cancer. 2012 Feb;22(2):260-6. doi: 10.1097/IGC.0b013e318230c264.

PMID:
22080878
7.

Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.

Kuku S, Williams M, McCormack M.

Int J Gynecol Cancer. 2013 Jul;23(6):1056-64. doi: 10.1097/IGC.0b013e3182978328.

PMID:
23765205
8.

Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women.

Mahdi H, Hou H, Kowk LL, Moslemi-Kebria M, Michener C.

Gynecol Oncol. 2014 Jun;133(3):512-7. doi: 10.1016/j.ygyno.2014.03.562. Epub 2014 Mar 24.

PMID:
24674830
9.

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.

Anticancer Res. 2000 May-Jun;20(3B):1977-84.

PMID:
10928137
10.

Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria.

Vargo JA, Boisen MM, Comerci JT, Kim H, Houser CJ, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Huang M, Courtney-Brooks M, Beriwal S.

Gynecol Oncol. 2014 Nov;135(2):190-5. doi: 10.1016/j.ygyno.2014.09.001. Epub 2014 Sep 9.

PMID:
25218303
11.

Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.

Chang-Halpenny CN, Natarajan S, Hwang-Graziano J.

Gynecol Oncol. 2013 Dec;131(3):598-603. doi: 10.1016/j.ygyno.2013.10.010. Epub 2013 Oct 14.

PMID:
24135679
12.

Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.

Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1145-53.

PMID:
11483323
13.

Metastatic endometrial endometrioid carcinoma with clear cell changes to the breast: a case report.

Farghaly H.

Ann Diagn Pathol. 2013 Feb;17(1):127-30. doi: 10.1016/j.anndiagpath.2011.06.004. Epub 2011 Nov 1.

PMID:
22048014
14.

Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.

Mulligan AM, Plotkin A, Rouzbahman M, Soslow RA, Gilks CB, Clarke BA.

Am J Surg Pathol. 2010 Aug;34(8):1132-8. doi: 10.1097/PAS.0b013e3181e6579c. Review.

PMID:
20588176
15.

Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer.

Nakayama K, Nagai Y, Ishikawa M, Aoki Y, Miyazaki K.

Int J Clin Oncol. 2010 Oct;15(5):440-6. doi: 10.1007/s10147-010-0081-6. Epub 2010 Apr 24.

PMID:
20419386
16.

The long-term survival of women with surgical stage II endometrioid type endometrial cancer.

Ayhan A, Taskiran C, Celik C, Yuce K.

Gynecol Oncol. 2004 Apr;93(1):9-13.

PMID:
15047207
17.

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.

Murphy KT, Rotmensch J, Yamada SD, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1272-6. Review.

PMID:
12654437
18.

Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.

AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC.

Gynecol Oncol. 2014 Jun;133(3):485-93. doi: 10.1016/j.ygyno.2014.03.567. Epub 2014 Mar 29.

19.

The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.

Sagae S, Saito T, Satoh M, Ikeda T, Kimura S, Mori M, Sato N, Kudo R.

Oncology. 2004;67(5-6):344-50.

PMID:
15713989
20.

Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.

Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Haddock MG, Keeney GL, Long HJ 3rd, Dowdy SC, Podratz KC.

Gynecol Oncol. 2013 Jun;129(3):478-85. doi: 10.1016/j.ygyno.2013.03.011. Epub 2013 Mar 25.

PMID:
23535279
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk